Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
- 11 November 2009
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 1 (6) , 6ra15
- https://doi.org/10.1126/scitranslmed.3000112
Abstract
A vector delivered into muscles of monkeys generates a natural regulatory molecule, which increases muscle size and strength and may be useful therapeutically.Keywords
This publication has 47 references indexed in Scilit:
- Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteinsAnnals of Neurology, 2009
- Inhibition of myostatin with emphasis on follistatin as a therapy for muscle diseaseMuscle & Nerve, 2009
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytesNature Biotechnology, 2008
- Facioscapulohumeral Muscular DystrophyNeurotherapeutics, 2008
- Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitorsProceedings of the National Academy of Sciences, 2008
- Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling PathwaysPLOS ONE, 2007
- Lack of myostatin results in excessive muscle growth but impaired force generationProceedings of the National Academy of Sciences, 2007
- The Heparin Binding Site of Follistatin Is Involved in Its Interaction with ActivinBiochemical and Biophysical Research Communications, 1995
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989
- Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicingBiochemical and Biophysical Research Communications, 1988